AI’s Exploration of the ‘Dark Genome’ and Its Impact on Cancer Research

AI has made significant strides in cancer research by delving into the ‘dark genome’ to revolutionize our understanding of cancer and pave the way for more effective treatments. By analyzing non-coding DNA sequences with AI technology, researchers can identify potential therapeutic targets and uncover novel biomarkers for early cancer detection. This intersection of AI and the ‘dark genome’ represents a paradigm shift in cancer research, offering unprecedented opportunities to unravel the complexities of cancer biology and transform the landscape of oncology.